Physician profile
Iris K Noh
NPI 1104189356
$1,231.50
in general payments reported to CMS, 2019-2025
17 companies · $790 in 2025
The $790 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $124 · 2024: $317 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $322.23 | 2024-2025 | Daxxify |
| Abbvie INC. | $203.35 | 2024-2025 | |
| Leo Pharma INC. | $144.75 | 2025 | Adbry, Anzupgo |
| Astrazeneca Pharmaceuticals LP | $123.84 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $71.98 | 2024-2025 | Libtayo, Dupixent |
| Lilly USA, LLC | $61.69 | 2025 | Taltz, Ebglyss |
| Galderma Laboratories, L.P. | $51.17 | 2025 | Nemluvio |
| Pfizer INC. | $43.19 | 2025 | |
| Arcutis Biotherapeutics, INC. | $38.63 | 2025 | Zoryve |
| Ucb, INC. | $27.94 | 2025 | Bimzelx |
| Organon LLC | $27.12 | 2025 | |
| Globus Medical, INC. | $25.75 | 2025 | Mars |
| Mimedx Group, INC. | $21.11 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $20.84 | 2025 | Sotyktu |
| Amgen INC. | $20.35 | 2025 | Otezla |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $15.53 | 2025 | |
| Biofrontera INC. | $12.03 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iris Noh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.